United Orthopedic Corporation (4129) Fair Value & Analysis
Healthcare · TW · Market cap 8.7B TWD
Fair value as of: Jun 24, 2026
Analysis
United Orthopedic Corporation (4129) currently trades at 90.10 TWD, while our model-based Fair Value estimate is 128.32 TWD — implying the stock looks roughly 42.4% undervalued today. We read business quality at 93/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical equipment in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee joints, including artificial knee replacement joints, revision knee replacement systems, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; spinal products comprising vertebral fixation devices; injury and other orthopedic products that consist of orthopedic internal fixation, bone plates, bone nails, bone pins, and bone screws and products; and OEM products, such as orthopedic internal fixation. It also provides its manufacturing equipment, as well as special metal and plastic materials. The company was incorporated in 1993 and is headqu…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is United Orthopedic Corporation (4129) undervalued?
What is the fair value of 4129?
What is the quality score of 4129?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.